Divis Laboratories share price
You have to be logged in to add this to Watchlist.Divis Laboratories is trading -3.46% lower at Rs 4,467.45 as compared to its last closing price. Divis Laboratories has been trading in the price range of 4,652.15 & 4,445.65. Divis Laboratories has given 14.35% in this year & -3.00% in the last 5 days.
Divis Laboratories has TTM P/E ratio 57.16 as compared to the sector P/E of 45.06.There are 22 analysts who have initiated coverage on Divis Laboratories. There are 3 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 6 analysts have given the stock a sell rating.
The company posted a net profit of 538.00 Crores in its last quarter.
Listed peers of Divis Laboratories include Sun Pharmaceutical Industries (-0.84%), Divis Laboratories (-3.46%), Cipla (-1.29%) etc.
Divis Laboratories has a 51.92% promoter holding & 48.08% public holding.The Mutual Fund holding in Divis Laboratories was at 7.24% in 31 Mar 2024. The MF holding has increased from the last quarter. The FII holding in Divis Laboratories was at 14.68% in 31 Mar 2024. The FII holding has decreased from the last quarter.
Divis Laboratories share price range
|
| ||||
|
| ||||
Divis Laboratories share Key Metrics
| Market Cap ( ₹ Cr.) | 1,18,510.50 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Divis Laboratories Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 25-May-24 | Audited Results & Dividend |
| 10-Feb-24 | Quarterly Results |
| 06-Nov-23 | Quarterly Results |
| 14-Aug-23 | Quarterly Results |
| 20-May-23 | Audited Results & Final Dividend |
| 03-Feb-23 | Quarterly Results |
| 07-Nov-22 | Quarterly Results |
| 12-Aug-22 | Quarterly Results |
| 23-May-22 | Audited Results & Dividend |
| 11-Feb-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 28-Aug-23 | 20-May-23 | AGM |
| 22-Aug-22 | 04-Jul-22 | AGM |
| 28-Mar-22 | 24-Feb-22 | POM |
| 30-Aug-21 | 02-Aug-21 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 27-May-24 | 02-Aug-24 | - | 30 |
| 22-May-23 | 11-Aug-23 | 11-Aug-23 | 30 |
| 23-May-22 | 12-Aug-22 | 11-Aug-22 | 30 |
| 31-May-21 | - | 17-Aug-21 | 20 |
FAQs about Divis Laboratories share price
Divis Laboratories is trading at 4467.45 as on Mon Jul 08 2024 10:15:29. This is -3.46% lower as compared to its previous closing price of 4627.60.
The market capitalization of Divis Laboratories is 118596.76 Cr as on Mon Jul 08 2024 10:15:29.
The average broker rating on Divis Laboratories is Sell. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 7 analysts have given a hold rating
- 6 analysts have given a sell rating
- 5 analysts have given a strong sell rating
The 52 wk high for Divis Laboratories is 4670.20 whereas the 52 wk low is 3300.00
Divis Laboratories can be analyzed on the following key metrics -
- TTM P/E: 57.16
- Sector P/E: 45.06
- Dividend Yield: 0.67%
- D/E ratio: 0.00
Divis Laboratories reported a net profit of 1600.00 Cr in 2024.
Divis Laboratories Quick Links
Divis Laboratories Dividend Divis Laboratories Bonus Divis Laboratories News Divis Laboratories AGM Divis Laboratories Rights Divis Laboratories Splits Divis Laboratories Board Meetings Divis Laboratories Key Metrics Divis Laboratories Shareholdings Divis Laboratories Profit Loss Divis Laboratories Balance Sheet Divis Laboratories Cashflow Divis Laboratories Q1 Results Divis Laboratories Q2 Results Divis Laboratories Q3 Results Divis Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks